(1)
Freimann, H.; Calderoni, A.; Cornu, P.; Olie, R. Daily Practice Use of Bortezomib in relapsed/refractory Multiple Myeloma: Safety/Efficacy Results of a Compassionate Use Program in Switzerland. Swiss Med Wkly 2007, 137, 317-322.